🔎 Trials Near Me

Utama › Kanser Salur Empedu (Kolangiokarsinoma) › Illinois

Kajian klinikal Kanser Salur Empedu (Kolangiokarsinoma) di Illinois

8 kajian untuk Kanser Salur Empedu (Kolangiokarsinoma) sedang mencari peserta di lokasi di Illinois.

Bandar di Illinois

Teks kajian rasmi (Bahasa Inggeris)

A Study of PHST001 in Advanced Solid Tumors

  • University of Chicago Medical Center, Chicago
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06840886

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

  • City of Hope - Chicago Cancer Center (Site 128), Zion
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07265674

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

  • University Chicago Medicine, Chicago
  • Carle Cancer Center, Urbana
  • Midwestern Regional Medical Center, City of Hope Chicago, Zion
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05732831

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

  • Rush University Medical Center, Chicago
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Jul 2026 · NCT07717437

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

  • University Of Chicago Medical Center, Chicago
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT05874414

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

  • The University of Chicago Medical Center - Oncology, Chicago
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Jul 2026 · NCT07169734

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Chicago
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

The Dragon PLC Trial (DRAGON-PLC)

  • Rush University Medical Center, Chicago
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Mei 2025 · NCT06914648

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.